Agilent Technologies (A) Stock Price, Quote & News

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufact...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 800 227 9770

Website: www.agilent.com

Address:

5301 Stevens Creek Boulevard, Santa Clara, United States

Dr_Stoxx Jun. 25 at 7:48 PM

$A in the strong medtech space. Note the OBV indicator, how strong it is here with price still pretty muted. (just added this to the mix).

0 · Reply

liamsniperalert Jun. 25 at 6:23 PM

$3.40 on $A here. 126% GAIN.🏆🗻

0 · Reply

Offgridliving Jun. 25 at 4:39 PM

$A vivk stock 40 cents share. About to pop News today 420 million renvue contact for oil. Current mirco cap 1.6 million. Almost 400% mirco cap. How many stocks have a deal 400 times micro cap? Just in one yearly deal? Cheap shares won't last long. Think about it 400 times micro cap in renvue

0 · Reply

Noxcapitaltrade Jun. 25 at 2:12 PM

$3.40 on $A here. 🥷 126% GAIN. ☢️☢️☢️

0 · Reply

Noxcapitaltrade Jun. 25 at 1:41 PM

$3.00 on $A here. 🥷 100% GAIN. ☢️☢️☢️

0 · Reply

Noxcapitaltrade Jun. 24 at 2:34 PM

$A 140 CALL 7/17 HERE🚨☢️

0 · Reply

VeltrixCapitalOfficial Jun. 24 at 2:34 PM

6x potential 🔥🚨 $A 140 CALL 7/17 avg 1.50🚨

0 · Reply

liamsniperalert Jun. 24 at 2:33 PM

$A 140 CALL 7/17 avg 1.50🗻

0 · Reply

Noxcapitaltrade Jun. 24 at 2:32 PM

$A 135 CALL 7/17 avg 1.50🚨

0 · Reply

SuperGreenToday Jun. 24 at 12:25 AM

$A Share Price: $126.70 Contract Selected: Nov 20, 2026 $125 Calls Buy Zone: $10.12 – $12.50 Target Zone: $19.18 – $23.44 Potential Upside: 79% ROI Time to Expiration: 149 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Agilent completes acquisition of Biocare Medical

Jun 25, 2026, 8:06 AM EDT - 18 hours ago

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

Jun 25, 2026, 8:00 AM EDT - 18 hours ago

Agilent Completes Acquisition of Biocare Medical

Jun 24, 2026, 6:45 AM EDT - 1 day ago

UMH PROPERTIES, INC. WELCOMES THE 21ST CENTURY ROAD TO HOUSING ACT: A MAJOR BOOST FOR AFFORDABLE MANUFACTURED HOUSING

UMH

Jun 23, 2026, 2:00 PM EDT - 2 days ago

Tradeweb Announces Date for Second Quarter 2026 Financial Results

Jun 11, 2026, 9:35 AM EDT - 14 days ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 7, 2026 in BitGo Holdings, Inc. Lawsuit - BTGO

BTGO

2026-06-11T09:50:53.000Z - 14 days ago

Agilent initiated with a Neutral at Piper Sandler

Jun 3, 2026, 9:20 AM EDT - 22 days ago

Agilent Technologies Transcript: Jefferies Global Healthcare Conference 2026

2026-06-03T11:24:55.000Z - 22 days ago

Agilent announces collaboration with OpenAI, BCG

Jun 3, 2026, 7:00 AM EDT - 22 days ago

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

2026-06-03T09:32:42.000Z - 22 days ago

Agilent price target lowered to $165 from $180 at HSBC

2026-06-02T20:50:31.000Z - 23 days ago

Agilent receives FDA approval for expanded use of PD-L1 IHC 22C3 pharmDx

Jun 2, 2026, 4:15 PM EDT - 23 days ago

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

2026-06-02T11:38:30.000Z - 23 days ago

Agilent price target raised to $155 from $145 at BofA

2026-06-01T21:11:49.000Z - 24 days ago

Agilent assumed with a Peer Perform at Wolfe Research

2026-06-01T20:54:03.000Z - 24 days ago

Agilent initiated with a Peer Perform at Wolfe Research

2026-05-28T15:46:53.000Z - 4 weeks ago

Agilent price target raised to $155 from $153 at RBC Capital

2026-05-28T13:15:50.000Z - 4 weeks ago

Agilent price target raised to $155 from $147 at TD Cowen

2026-05-28T12:51:27.000Z - 4 weeks ago

Agilent introduces OpenLab Sync lab execution system

May 28, 2026, 8:00 AM EDT - 4 weeks ago

Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

2026-05-28T11:09:27.000Z - 4 weeks ago

Agilent price target raised to $158 from $156 at Baird

2026-05-28T10:35:31.000Z - 4 weeks ago

Agilent upgraded to Buy at BofA after ‘solid’ beat in Q2

2026-05-28T10:31:29.000Z - 4 weeks ago

Agilent price target lowered to $160 from $165 at Wells Fargo

2026-05-28T10:16:39.000Z - 4 weeks ago

Agilent price target raised to $145 from $140 at Barclays

May 27, 2026, 4:30 PM EDT - 4 weeks ago

Agilent Technologies Earnings Call Transcript: Q2 2026

May 27, 2026, 4:30 PM EDT - 4 weeks ago

Agilent Technologies Slides: Q2 2026

May 27, 2026, 4:30 PM EDT - 4 weeks ago

Agilent Technologies Earnings release: Q2 2026

May 27, 2026, 4:30 PM EDT - 4 weeks ago

Agilent Technologies Quarterly report: Q2 2026

May 27, 2026, 4:09 PM EDT - 4 weeks ago

Agilent raises 2026 profit forecast on strong demand for lab tools

May 27, 2026, 4:05 PM EDT - 4 weeks ago

Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

May 26, 2026, 8:00 AM EDT - 4 weeks ago

Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control

May 26, 2026, 8:00 AM EDT - 4 weeks ago

Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality

May 22, 2026, 8:00 AM EDT - 4 weeks ago

Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis

May 21, 2026, 8:00 AM EDT - 5 weeks ago

Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed

May 20, 2026, 4:27 PM EDT - 5 weeks ago

Agilent Announces Cash Dividend of 25.5 Cents per Share

May 19, 2026, 8:00 AM EDT - 5 weeks ago

Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026

May 11, 2026, 4:15 PM EDT - 6 weeks ago

Agilent to Participate in Jefferies Global Healthcare Conference

May 4, 2026, 8:00 AM EDT - 7 weeks ago

Agilent Names Michael Buckner as Chief Legal Officer

Apr 28, 2026, 4:15 PM EDT - 2 months ago

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

Apr 21, 2026, 8:00 AM EDT - 2 months ago

Axion BioSystems and Agilent Technologies Resolve Litigation

Apr 15, 2026, 8:00 AM EDT - 2 months ago

Agilent Showcases Cancer Research Solutions at AACR 2026

Apr 1, 2026, 8:00 AM EDT - 3 months ago

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Mar 27, 2026, 7:00 AM EDT - 3 months ago

Agilent Technologies Slides: Corporate presentation

Mar 26, 2026, 8:00 AM EDT - 3 months ago

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

Mar 19, 2026, 8:00 AM EDT - 3 months ago

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Mar 11, 2026, 8:00 AM EDT - 3 months ago

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

Mar 9, 2026, 3:09 AM EDT - 3 months ago

Agilent to acquire Biocare Medical in $950 million all-cash deal

Mar 9, 2026, 3:05 AM EDT - 3 months ago

Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies

Mar 9, 2026, 3:00 AM EDT - 3 months ago

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

Mar 3, 2026, 11:10 AM EST - 4 months ago

Agilent Technologies Transcript: TD Cowen 46th Annual Health Care Conference

Feb 25, 2026, 5:24 PM EST - 4 months ago

Agilent reports in-line first quarter, says results hurt by US snowstorm

Feb 25, 2026, 4:30 PM EST - 4 months ago

Agilent Technologies Earnings Call Transcript: Q1 2026

Feb 25, 2026, 4:30 PM EST - 4 months ago

Agilent Technologies Quarterly report: Q1 2026

Feb 25, 2026, 4:30 PM EST - 4 months ago

Agilent Technologies Earnings release: Q1 2026

Feb 25, 2026, 4:30 PM EST - 4 months ago

Agilent Technologies Slides: Q1 2026

Feb 25, 2026, 4:05 PM EST - 4 months ago

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Feb 23, 2026, 4:15 PM EST - 4 months ago

Agilent to Participate in TD Cowen's 46th Annual Health Care Conference

Feb 11, 2026, 8:00 AM EST - 4 months ago

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Feb 11, 2026, 6:45 AM EST - 4 months ago

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Feb 6, 2026, 7:00 AM EST - 4 months ago

Agilent Technologies Proxy statement: Proxy Filing

Feb 6, 2026, 7:00 AM EST - 4 months ago

Agilent Technologies Proxy statement: Proxy Filing

Feb 4, 2026, 8:00 AM EST - 5 months ago

Agilent Showcases Next‑Generation Automated Solutions at SLAS2026

Feb 2, 2026, 4:15 PM EST - 5 months ago

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25

Jan 23, 2026, 8:00 AM EST - 5 months ago

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System

Jan 23, 2026, 7:00 AM EST - 5 months ago

Agilent Technologies Proxy statement: Proxy Filing

Jan 13, 2026, 12:00 PM EST - 5 months ago

Agilent Technologies Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:00 PM EST - 5 months ago

Agilent Technologies Slides: 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:31 AM EST - 6 months ago

Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 4, 2025, 9:00 AM EST - 7 months ago

Agilent Technologies Transcript: Citi Annual Global Healthcare Conference 2025

Dec 1, 2025, 8:00 AM EST - 7 months ago

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

Nov 25, 2025, 1:24 PM EST - 7 months ago

Top small-cap plays for 2026

COHR DG EW TXT VLO

Nov 24, 2025, 4:30 PM EST - 7 months ago

Agilent Technologies Earnings Call Transcript: Q4 2025

Nov 24, 2025, 4:30 PM EST - 7 months ago

Agilent Technologies Annual report: Q4 2025

Nov 24, 2025, 4:30 PM EST - 7 months ago

Agilent Technologies Earnings release: Q4 2025

Nov 24, 2025, 4:30 PM EST - 7 months ago

Agilent Technologies Slides: Q4 2025

Nov 24, 2025, 4:10 PM EST - 7 months ago

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

Nov 24, 2025, 4:07 PM EST - 7 months ago

Agilent beats quarterly revenue estimates on strong demand for lab tools

Nov 24, 2025, 1:50 PM EST - 7 months ago

Josh Brown's ‘best stocks in the market': Health Care

LLY MTD TMO XLV

Nov 19, 2025, 4:15 PM EST - 7 months ago

Agilent Announces Cash Dividend of 25.5 Cents Per Share

Nov 18, 2025, 5:10 PM EST - 7 months ago

Agilent to Participate in Citi's 2025 Global Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 8 months ago

Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics

Oct 30, 2025, 4:15 PM EDT - 8 months ago

Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24

Oct 27, 2025, 4:15 PM EDT - 8 months ago

Agilent Names Adam S. Elinoff as Chief Financial Officer

Sep 30, 2025, 8:00 AM EDT - 9 months ago

Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening

Sep 30, 2025, 7:00 AM EDT - 9 months ago

Agilent Technologies Slides: Investor Presentation

Sep 29, 2025, 8:00 AM EDT - 9 months ago

Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing

Dr_Stoxx Jun. 25 at 7:48 PM

$A in the strong medtech space. Note the OBV indicator, how strong it is here with price still pretty muted. (just added this to the mix).

0 · Reply

liamsniperalert Jun. 25 at 6:23 PM

$3.40 on $A here. 126% GAIN.🏆🗻

0 · Reply

Offgridliving Jun. 25 at 4:39 PM

0 · Reply

Noxcapitaltrade Jun. 25 at 2:12 PM

$3.40 on $A here. 🥷 126% GAIN. ☢️☢️☢️

0 · Reply

Noxcapitaltrade Jun. 25 at 1:41 PM

$3.00 on $A here. 🥷 100% GAIN. ☢️☢️☢️

0 · Reply

Noxcapitaltrade Jun. 24 at 2:34 PM

$A 140 CALL 7/17 HERE🚨☢️

0 · Reply

VeltrixCapitalOfficial Jun. 24 at 2:34 PM

6x potential 🔥🚨 $A 140 CALL 7/17 avg 1.50🚨

0 · Reply

liamsniperalert Jun. 24 at 2:33 PM

$A 140 CALL 7/17 avg 1.50🗻

0 · Reply

Noxcapitaltrade Jun. 24 at 2:32 PM

$A 135 CALL 7/17 avg 1.50🚨

0 · Reply

SuperGreenToday Jun. 24 at 12:25 AM

0 · Reply

BillionerOfKing Jun. 23 at 11:05 PM

$A Current Stock Price: $126.70 Contracts to trade: $125.0 A Jul 17 2026 Call Entry: $4.60 Exit: $7.12 ROI: 55% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

JackDarwin Jun. 20 at 9:45 AM

$A Bullish Harami Candlestick Pattern Formed at Downtrend

0 · Reply

dark_gamma Jun. 19 at 3:32 PM

$AUR Premium Heatmap & Key Strikes Last: $A Key Levels to Watch: Resistance: $6.29 ($35.3M) | $6.39 ($37.6M) Support: $6.25 ($53.3M) | $6.21 ($29.3M) | $6.14 ($62.6M) Stay informed with our daily market updates - follow for the latest insights #AUR #Options #Trading #GEX #GammaExposure

0 · Reply

wezen20 Jun. 17 at 6:45 PM

$SPY $A friend of mine said $META $605 close

1 · Reply

Vrodcarpediem Jun. 11 at 5:28 PM

$AMD $AMDL $AMD $A I JUST LOADED UP LOOK OUT

0 · Reply

NVDAMillionaire Jun. 9 at 5:16 PM

$A Great piece that accurately captures A's current position. So if you want to refresh your understanding of A or learn about A for the first time, this is essential reading. https://everyticker.com/quote/A/analysis/ignite-driven-margin-expansion-meets-installed-base-moats-at-agilent-technologies-nyse-a

0 · Reply

KornieAwareness7 Jun. 5 at 5:38 PM

$A holding tough

2 · Reply

KornieAwareness7 Jun. 3 at 3:03 PM

$A hmmmm Open collab

1 · Reply

MankindCapital Jun. 2 at 8:26 PM

$A https://www.businesswire.com/news/home/20260602060341/en/Agilent-Receives-FDA-Approval-for-Expanded-Use-of-PD-L1-IHC-22C3-pharmDx-on-Dako-Omnis-in-Esophageal-Squamous-Cell-Carcinoma-Triple-Negative-Breast-Cancer-Cervical-Cancer-and-Gastric-or-Gastroesophageal-Junction-Adenocarcinoma

0 · Reply

SPY700baby May. 29 at 2:35 PM

$NOW get in now before the big pop $SPY $MSTR $A

1 · Reply

semiguy May. 29 at 12:52 AM

$PLTR $PM $O $A I told you last week - Magnachip to Showcase MV MOSFET Portfolio for AI Servers and Data Centers Alongside Its Broader Power Semiconductor Portfolio at PCIM Europe 2026 SYMBOL(MX) Magnachip a small cap power solutions semiconductor company based in South Korea. • MKT Cap of $230 million. • Revenue of $180 million. • 8 inch foundry worth approximately 200 million – 36K wafers a month • Cash of $50 million, trading at $5.70 a share. ( as of last Friday) • Won’t be at this price for long. Magnachip to Showcase MV MOSFET Portfolio for AI Servers and Data Centers Alongside Its Broader Power Semiconductor Portfolio at PCIM Europe https://www.businesswire.com/news/home/20260526332549/en/Magnachip-to-Showcase-MV-MOSFET-Portfolio-for-AI-Servers-and-Data-Centers-Alongside-Its-Broader-Power-Semiconductor-Portfolio-at-PCIM-Europe-2026

0 · Reply

Dogstocks12 May. 28 at 11:53 PM

$A Can't believe this paid my calls 110% today! Thanks! 🤠 Glta

0 · Reply

Market Cap	37.18B
Revenue (ttm)	6.95B
Net Income (ttm)	1.30B
EPS (ttm)	N/A
PE Ratio	21.80
Forward PE	21.13
Profit Margin	18.75%
Debt to Equity Ratio	0.43

Volume	2,026,900
Avg Vol	2,401,282
Day's Range	N/A - N/A
Shares Out	282.43M
Stochastic %K	79%
Beta	1.26
Analysts	Strong Sell
Price Target	$162.00